Eating Disorders: Pathophysiology, Clinical Manifestations, Diagnostic Workup, and Multimodal Treatment

Eating disorders are complex, bio-psychosocial psychiatric conditions characterized by severe, persistent disturbances in eating behaviors, altered body image perception, and distressed thoughts regarding weight, shape, and food intake. Encompassing conditions such as Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder (BED), and Avoidant/Restrictive Food Intake Disorder (ARFID), these conditions carry the highest mortality rates of any mental health disorders, driven by severe medical complications and elevated suicide risk.

Far from being lifestyle choices or superficial preoccupations with appearance, eating disorders stem from intricate interactions between genetic vulnerability, neurochemical dysregulation, cognitive traits, and sociocultural factors. Understanding their biological underpinnings, identifying systemic medical sequelae early, applying standardized diagnostic criteria, and implementing multidisciplinary treatment protocols are vital for achieving durable medical stabilization and psychological recovery.

Etiology and Pathophysiology

The development of eating disorders involves genetic predispositions, neurocircuitry alterations, and environmental stressors:

+--------------------------------------------------------------------------+
|                   PATHOPHYSIOLOGY OF EATING DISORDERS                    |
|                                                                          |
|   Genetic & Neurochemical Factors --->   Alterations in Central Reward   |
|  (Heritability 40-60%, 5-HT/DA          & Insular Cortical Circuits      |
|   pathway dysregulation)                 (Distorted body perception)     |
|                                                     |                    |
|                                                     v                    |
|   Multisystem Endocrine Collapse <---   Severe Malnutrition & Purging    |
|  (Hypothalamic-pituitary shutdown,       (Electrolyte shifts, cardiac    |
|   osteopenia, metabolic slowdown)         arrhythmias, organ atrophy)    |
+--------------------------------------------------------------------------+
  1. Neurobiological and Genetic Factors: Family and twin studies demonstrate a strong genetic heritability for eating disorders (40% to 60%40\%\text{ to }60\%40% to 60%). Dysregulation within central serotonergic (5-HT5\text{-HT}5-HT) and dopaminergic (DA) pathways alters impulse control, mood regulation, and satiety signaling. Imaging reveals structural and functional alterations within the insular cortex (responsible for interoceptive awareness and bodily perception) and fronto-striatal reward circuits.
  2. Endocrine and Metabolic Dysregulation: Chronic caloric restriction triggers a protective state of systemic hypometabolism. The Hypothalamic-Pituitary-Gonadal (HPG) axis shuts down, producing hypogonadotropic hypogonadism (amenorrhea in females, low testosterone in males). Thyroid hormone conversion shifts toward inactive reverse T3T_3T3​, and cortisol levels rise to maintain gluconeogenesis.
  3. Psychosocial and Personality Traits: Perfectionism, obsessive-compulsive tendencies, cognitive inflexibility, low self-esteem, negative affectivity, internalized aesthetic ideals, and history of adverse childhood experiences act as primary psychological drivers.

Primary Diagnostic Categories and Clinical Features

The Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) categorizes eating disorders into distinct diagnostic groups based on psychological and behavioral patterns:

Clinical EntityPrimary Diagnostic FeaturesAssociated Physical & Laboratory Findings
Anorexia Nervosa (AN)Restriction of energy intake leading to significantly low body weight; intense fear of gaining weight; distorted body image. Subtyped as Restricting or Binge-Eating/Purging.Sinus bradycardia, hypothermia, lanugo hair, leukopenia, elevated BUN, osteopenia/osteoporosis, prolonged QTc interval.
Bulimia Nervosa (BN)Recurrent episodes of binge eating paired with inappropriate compensatory behaviors (self-induced vomiting, laxatives, excessive exercise) at least weekly for 3 months.Russell’s sign (knuckle calluses), dental enamel erosion, parotid gland hypertrophy (“chipmunk cheeks”), hypokalemia, metabolic alkalosis.
Binge-Eating Disorder (BED)Recurrent binge eating episodes accompanied by marked distress and a feeling of lack of control, without regular compensatory behaviors.Metabolic syndrome, Type 2 diabetes mellitus, non-alcoholic fatty liver disease, hypertension, hyperlipidemia.
ARFIDAvoidance or restriction of food intake based on sensory characteristics, fear of aversion consequences, or lack of interest, leading to nutritional failure without body image distortion.Significant weight loss, nutritional deficiencies (e.g., scurvy, anemia), dependence on enteral feeding, macro/micronutrient deficits.

Medical Complications and Diagnostic Evaluation

Severe caloric restriction, purging behaviors, and rapid weight fluctuations impact nearly every organ system in the body:

1. Cardiovascular and Hematological Complications

Malnutrition causes myocardial muscle atrophy, reducing cardiac output and left ventricular mass. Patients present with sinus bradycardia (resting heart rate <50 beats/min<50\text{ beats/min}<50 beats/min), orthostatic hypotension, and pericardial effusions. Purging-induced electrolyte shifts (particularly hypokalemia and hypomagnesemia) prolong the QTc interval, predisposing patients to fatal ventricular arrhythmias such as Torsades de Pointes.

2. Comprehensive Diagnostic Workup

Physical assessment must be paired with structured laboratory testing:

  • Complete Blood Count (CBC): Reveals bone marrow suppression leading to leukopenia, anemia, and thrombocytopenia.
  • Comprehensive Metabolic Panel (CMP): Evaluates serum potassium, sodium, chloride, bicarbonate, magnesium, and phosphate. Self-induced vomiting characteristically produces hypokalemic, hypochloremic metabolic alkalosis, whereas laxative abuse leads to metabolic acidosis.
  • Electrocardiogram (ECG): Mandatory screening tool to check for bradycardia, conduction delays, or QTc prolongation before initiating psychotropic medications.
  • Bone Mineral Density (DXA Scan): Evaluates for osteopenia or osteoporosis in individuals with prolonged amenorrhea or severe low weight lasting longer than 6 months.

Multimodal Evidence-Based Management Protocols

Treating eating disorders requires a multidisciplinary team combining medical physicians, psychiatrists, clinical psychologists, and specialized registered dietitians:

1. Medical Stabilization and The Refeeding Syndrome Risk

Severely malnourished patients require medical hospitalization when presenting with unstable vital signs (e.g., heart rate <40 beats/min<40\text{ beats/min}<40 beats/min, blood pressure <90/60 mmHg<90/60\text{ mmHg}<90/60 mmHg), acute electrolyte imbalances, or body mass index (BMI) <15 kg/m2<15\text{ kg/m}^2<15 kg/m2.

Refeeding Syndrome: A life-threatening metabolic complication occurring when nutrition is reintroduced to a severely malnourished individual. Carbohydrate intake triggers massive insulin surge, driving extracellular phosphate, potassium, and magnesium into cells for ATP production and glycogen synthesis. Hypophosphatemia causes acute cardiac failure, respiratory arrest, seizures, rhabdomyolysis, and death. Refeeding must start cautiously with continuous electrolyte monitoring and prophylactic phosphate/thiamine supplementation.

2. Evidence-Based Psychotherapy

  • Family-Based Treatment (FBT / Maudsley Model): The first-line, gold-standard therapy for adolescents with Anorexia Nervosa. Unites parents to take control of nutritional recovery and weight restoration before gradually transitioning control back to the adolescent.
  • Enhanced Cognitive Behavioral Therapy (CBT-E): First-line individual treatment for adults with Bulimia Nervosa, Binge-Eating Disorder, and non-underweight eating disorders. Targets cognitive distortions regarding body shape, dietary restraint, and binge-purge cycles.

3. Targeted Pharmacotherapy

  • Bulimia Nervosa: Fluoxetine (a selective serotonin reuptake inhibitor [SSRI]) is FDA-approved at high doses (60 mg60\text{ mg}60 mg daily), significantly reducing binge-purge frequency.
  • Binge-Eating Disorder: Lisdexamfetamine (a central nervous system stimulant) and SSRIs reduce binge frequency and compulsive eating drives.
  • Anorexia Nervosa: Pharmacotherapy plays a limited role; however, low-dose olanzapine (an atypical antipsychotic) can help ease obsessive food anxiety, promote weight restoration, and manage severe cognitive rigidity.

Conclusion

Eating disorders are severe, bio-psychosocial conditions that trigger profound multi-system medical complications and psychological distress. By identifying early physical signs—such as bradycardia, electrolyte shifts, and body image distortion—executing targeted diagnostic evaluations, managing refeeding protocols safely, and delivering evidence-based psychotherapies alongside specialized pharmacotherapy, multidisciplinary healthcare teams can restore physical stability, rebuild healthy relationships with food, and promote long-term recovery.